Grifols SA (GRFS)
8.72
+0.03
(+0.35%)
USD |
NASDAQ |
Nov 16, 16:00
8.72
0.00 (0.00%)
After-Hours: 20:00
Grifols Net Income (Quarterly) : 208.24M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 208.24M |
| June 30, 2026 | 212.78M |
| March 31, 2026 | 102.95M |
| December 31, 2025 | 146.39M |
| September 30, 2025 | 167.61M |
| June 30, 2025 | 156.85M |
| March 31, 2025 | 97.27M |
| December 31, 2024 | 89.37M |
| September 30, 2024 | 90.06M |
| June 30, 2024 | 26.66M |
| March 31, 2024 | 24.18M |
| December 31, 2023 | 84.17M |
| September 30, 2023 | 98.28M |
| June 30, 2023 | 82.71M |
| March 31, 2023 | 13.76M |
| March 31, 2021 | 181.86M |
| December 31, 2020 | 192.46M |
| September 30, 2020 | 334.14M |
| June 30, 2020 | 64.02M |
| March 31, 2020 | 224.23M |
| December 31, 2019 | 223.91M |
| September 30, 2019 | 168.74M |
| June 30, 2019 | 202.66M |
| March 31, 2019 | 129.76M |
| December 31, 2018 | 145.96M |
| Date | Value |
|---|---|
| September 30, 2018 | 172.85M |
| June 30, 2018 | 208.42M |
| March 31, 2018 | 175.59M |
| December 31, 2017 | 271.48M |
| September 30, 2017 | 180.15M |
| June 30, 2017 | 158.20M |
| March 31, 2017 | 142.54M |
| December 31, 2016 | 149.83M |
| September 30, 2016 | 157.84M |
| June 30, 2016 | 157.25M |
| March 31, 2016 | 137.62M |
| December 31, 2015 | 143.31M |
| September 30, 2015 | 155.52M |
| June 30, 2015 | 146.87M |
| March 31, 2015 | 143.69M |
| December 31, 2014 | 163.14M |
| September 30, 2014 | 150.38M |
| June 30, 2014 | 141.70M |
| March 31, 2014 | 163.92M |
| December 31, 2013 | 106.33M |
| September 30, 2013 | 110.58M |
| June 30, 2013 | 118.67M |
| March 31, 2013 | 118.23M |
| December 31, 2012 | 76.85M |
| September 30, 2012 | 78.35M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -55.06M |
| Evaxion AS | -3.724M |
| DBV Technologies SA | -64.43M |
| Cellectis SA | -21.79M |
| Akari Therapeutics Plc | -4.841M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.347B |
| Total Expenses (Quarterly) | 2.161B |
| EPS Diluted (Quarterly) | 0.2739 |
| Enterprise Value | 14.98B |
| Gross Profit Margin (Quarterly) | 39.56% |
| Profit Margin (Quarterly) | 8.87% |
| Earnings Yield | 9.52% |
| Operating Earnings Yield | 24.38% |
| Normalized Earnings Yield | 9.524 |